| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nature immunology 21 (11), 1336-1345, 2020 | 1192 | 2020 |
| Oxford Immunology Network Covid-19 Response T cell Consortium. ISARIC4C Investigators Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent … Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... Nat. Immunol 21, 1336-1345, 2020 | 97 | 2020 |
| Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection W Paes, G Leonov, T Partridge, T Chikata, H Murakoshi, A Frangou, ... Proceedings of the National Academy of Sciences 116 (49), 24748-24759, 2019 | 53 | 2019 |
| Recombinant polymorphic membrane protein D in combination with a novel, second-generation lipid adjuvant protects against intra-vaginal Chlamydia trachomatis infection in mice W Paes, N Brown, AM Brzozowski, R Coler, S Reed, D Carter, M Bland, ... Vaccine 34 (35), 4123-4131, 2016 | 32 | 2016 |
| Intramuscular immunisation with chlamydial proteins induces Chlamydia trachomatis specific ocular antibodies A Badamchi-Zadeh, PF McKay, MJ Holland, W Paes, A Brzozowski, ... PLoS One 10 (10), e0141209, 2015 | 26 | 2015 |
| Elucidation of the signatures of proteasome-catalyzed peptide splicing W Paes, G Leonov, T Partridge, A Nicastri, N Ternette, P Borrow Frontiers in immunology 11, 563800, 2020 | 25 | 2020 |
| Hypoxic microenvironment shapes HIV-1 replication and latency X Zhuang, I Pedroza-Pacheco, I Nawroth, AE Kliszczak, A Magri, W Paes, ... Communications Biology 3 (1), 376, 2020 | 24 | 2020 |
| Identification of immunodominant HIV-1 epitopes presented by HLA-C* 12: 02, a protective allele, using an immunopeptidomics approach T Chikata, W Paes, T Akahoshi, T Partridge, H Murakoshi, H Gatanaga, ... Journal of Virology 93 (17), 10.1128/jvi. 00634-19, 2019 | 16 | 2019 |
| Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients. T Dong, Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... | 13 | 2020 |
| The Chlamydia trachomatis PmpD adhesin forms higher order structures through disulphide-mediated covalent interactions W Paes, A Dowle, J Coldwell, A Leech, T Ganderton, A Brzozowski PLoS One 13 (6), e0198662, 2018 | 10 | 2018 |
| Large-scale immunopeptidome analysis reveals recurrent posttranslational splicing of cancer-and immune-associated genes R Levy, TA Regev, W Paes, N Gumpert, SC Shvefel, O Bartok, ... Molecular & cellular proteomics 22 (4), 2023 | 8 | 2023 |
| HLA binding of self-peptides is biased towards proteins with specific molecular functions V Karnaukhov, W Paes, IB Woodhouse, T Partridge, A Nicastri, ... bioRxiv, 2021 | 8 | 2021 |
| HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes V Karnaukhov, W Paes, IB Woodhouse, T Partridge, A Nicastri, ... Frontiers in Immunology 13, 1067463, 2022 | 7 | 2022 |
| Oxford Immunology Network Covid-19 Response Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... TCC, Investigators, IC, Cornall, RJ, Conlon, CP, Klenerman, P., Screaton, GR …, 0 | 6 | |
| COVID-19 RESPONSE Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ... TCC, INVESTIGATORS, IC, CORNALL RJ, CONLON CP, KLENERMAN P., SCREATON GR …, 2020 | 3 | 2020 |
| MARS: improved de novo peptide candidate selection for non-canonical antigen target discovery in cancer H Liao, C Barra, X Peng, I Woodhouse, A Tailor, R Parker, A Carré, ... | 2 | 2022 |
| A small molecule approach to drive novel neoantigen generation: First-in-class inhibitors of ERAP1 generate novel neoantigens driving anti-tumor effects A Leishman, W Paes, R Coulson, M Pinggera, J Sette, K Anderton, ... Cancer Research 82 (12_Supplement), 2065-2065, 2022 | 2 | 2022 |
| Impact of Micropolymorphism outside the peptide binding groove in the clinically relevant allele HLA-C* 14 on T cell responses in HIV-1 infection T Chikata, W Paes, N Kuse, T Partridge, H Gatanaga, Y Zhang, K Kuroki, ... Journal of virology 96 (10), e00432-22, 2022 | 2 | 2022 |
| 553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition P Joyce, M Quibell, J Shiers, C Tong, K Clark, N Ternette, K Anderton, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | 2 | 2021 |
| Corrigendum: elucidation of the signatures of proteasome-catalysed peptide splicing W Paes, G Leonov, T Partridge, A Nicastri, N Ternette, P Borrow Frontiers in Immunology 12, 755002, 2021 | 2 | 2021 |
